As synovial IL-17 expression is upregulated in RA, it has been observed that neutralization of IL-17 in mice significantly prevented joint swelling at day 1 of flare, suppressing joint inflammation and cartilage proteoglycan depletion at day 4 (98). The gene discussed is IL17A; the disease is rheumatoid arthritis.